Faverio P, Bonaiti G, Bini F, Vaghi A, & Pesci A. (2018). Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: A review of current evidence and potential place in therapy. Dove Medical Press.
Chicago Style (17th ed.) CitationFaverio P, Bonaiti G, Bini F, Vaghi A, and Pesci A. Mepolizumab as the First Targeted Treatment for Eosinophilic Granulomatosis with Polyangiitis: A Review of Current Evidence and Potential Place in Therapy. Dove Medical Press, 2018.
MLA (9th ed.) CitationFaverio P, et al. Mepolizumab as the First Targeted Treatment for Eosinophilic Granulomatosis with Polyangiitis: A Review of Current Evidence and Potential Place in Therapy. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.